FDA elevates Vitruvia's thyroid tablet recall to class I, its most serious risk level
FDA elevates Vitruvia's thyroid tablet recall to class I, its most serious risk levelThe U.S. Food and Drug Administration has upgraded a recall of Vitruvias Therapeutics’ 30mg thyroid tablets to a class I designation.
This marks the agency’s highest-risk category...
0

0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.